Active Ingredient History
Osilodrostat, sold under the brand name Isturisa, is a medication for the treatment of adults with Cushing's disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease. It is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Cushing Syndrome (approved 2020)
Adrenal Gland Neoplasms (Phase 2)
Adrenal Hyperplasia, Congenital (Phase 2)
Adrenocortical Hyperfunction (Phase 2)
Cushing Syndrome (Phase 3)
Essential Hypertension (Phase 2)
Hyperaldosteronism (Phase 2)
Hypertension (Phase 2)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Pituitary ACTH Hypersecretion (Phase 3)
Receptors, Corticotropin (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
